TABLE 2:

Age and MR measurements from symptomatic fragile X premutation carriers and control participants

Age (yr)Pons AP (mm)Pons Trans (mm)Pons RC (mm)MCP R (mm)MCP L (mm)IV Height (mm)Ant Horn (mm)Fr. Cereb-Vent IndexEvan’s IndexIII Width (mm)
Control participants
 Average66.1263129181811360.320.286.1
 Maximum76.0283331192214400.350.319.0
 Minimum56.0232726151410310.280.244.0
 SD6.11.71.71.41.11.91.22.70.020.021.4
Patients
 Average67.6222526131312440.400.3511.2
 Maximum77.0243129171716600.500.4615.0
 Minimum59.0191923998230.300.257.0
 SD4.71.22.91.82.02.02.58.00.050.052.7
P value0.46<.005<.005<.005<.005<.0050.21<.005<.005<.005<.005
  • Note.—AP indicates anteroposterior; Trans, transverse; RC, rostral-caudal; MCP, middle cerebellar peduncle; R, right; L, left; IV Height, vertical dimension of the fourth ventricle measured from the floor of the fourth ventricle to its apex on a midline sagittal image; Ant Horn, maximal width of both anterior horns; Fr. Cereb-Vent Index, ratio of maximal width of both anterior horns to the diameter of inner table of skull along the line of measurement of anterior horn transverse dimension; Evan’s index, ratio of maximal width of both anterior horns to the diameter of inner table of skull at its point of greatest transverse diameter on any image; III Width, width of third ventricle; Note that MCP R and MCP L are the narrowest oblique transverse dimension of the right and left middle cerebellar peduncles measured from an axial image. P values were derived from Student’s t test of control versus patient populations.